Company Information
Ask for more detail from the seller
Contact SupplierWe are manufacturer and exporter of Deflazacort API
Deflazacort is a corticosteroid used to treat Duchenne muscular dystrophy. Deflazacort, also known as Emflaza, is a corticosteroid prodrug used as an agent to manage Duchenne Muscular Dystrophy (DMD). It is marketed by Marathon Pharmaceuticals and was approved in February 2017 by the FDA.